Viking Therapeutics Launches Phase 1 Study of VK3019 for Weight Loss
SAN DIEGO, June 24, 2026 Viking Therapeutics (NASDAQ: VKTX) announced the initiation of a Phase 1 clinical trial evaluating...
Obesity treatment
Advertisement
Novo Nordisk Secures UK Approval for First Wegovy Weight-Loss Pill
BAGSVÆRD, Denmark, June 11, 2026 Novo Nordisk announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has...
Caliway Presents CBL-514 Data Showing Reduced Weight Regain with GLP-1 Therapies
June 10, 2026 – Taipei, Taiwan Caliway Biopharmaceuticals announced new preclinical data demonstrating the potential of its proprietary fat-reduction...
Novartis and Orionis Expand AI-Powered Molecular Glue Alliance
BOSTON, Massachusetts, USA and GHENT, Belgium, June 10, 2026 Orionis Biosciences and Novartis have announced a major multi-year strategic...
Teva Acquires Emalex to Advance Tourette Syndrome Therapy
TEL AVIV, Israel, June 10, 2026 Teva Pharmaceutical Industries Ltd. has completed its acquisition of Emalex Biosciences, strengthening its...
Advertisements
Eli Lilly and Shaquille O’Neal Raise Awareness of Treatable Sleep Apnea with Zepbound
INDIANAPOLIS, United States, June 10, 2026 Eli Lilly and Company has launched a nationwide awareness campaign featuring NBA legend...
Ascletis Showcases ASC30, ASC37 and ASC39 Obesity Data at ADA 2026
HONG KONG, June 8, 2026 Ascletis Pharma Inc. presented new clinical and preclinical data from its expanding obesity pipeline...
Ambrosia’s AMB-702 Shows Superior Weight Loss in Preclinical GLP-1 Studies
BOULDER, Colorado, June 5, 2026 Ambrosia Biosciences has unveiled promising preclinical data for AMB-702, its novel oral small-molecule GLP-1...
Lilly’s Foundayo Shows Strong Weight Loss Across Menopause
INDIANAPOLIS, Indiana, June 7, 2026 Eli Lilly and Company has announced new data demonstrating that Foundayo® (orforglipron), the only...
Zealand Pharma Reports Positive Phase 2 Petrelintide Data in Obesity
COPENHAGEN, Denmark, June 5, 2026 Zealand Pharma announced new results from its Phase 2 ZUPREME-1 clinical trial evaluating petrelintide,...
Advertisement
